As of 2025-07-11, the Relative Valuation of WuXi Biologics (Cayman) Inc (2269.HK) is 22.02 HKD. This relative valuation is based on P/E multiples. With the latest stock price at 25.70 HKD, the upside of WuXi Biologics (Cayman) Inc based on Relative Valuation is -14.3%.
The range of the Relative Valuation is 17.78 - 24.65 HKD.
| Range | Selected | |
| Trailing P/E multiples | 19.7x - 25.6x | 22.2x |
| Forward P/E multiples | 18.2x - 18.9x | 18.3x |
| Fair Price | 17.78 - 24.65 | 22.02 |
| Upside | -30.8% - -4.1% | -14.3% |
| Date | P/E |
| 2025-07-10 | 28.41 |
| 2025-07-09 | 28.63 |
| 2025-07-08 | 28.41 |
| 2025-07-07 | 27.70 |
| 2025-07-04 | 28.97 |
| 2025-07-03 | 28.52 |
| 2025-07-02 | 28.36 |
| 2025-06-30 | 28.36 |
| 2025-06-27 | 27.81 |
| 2025-06-26 | 27.64 |
| 2025-06-25 | 28.41 |
| 2025-06-24 | 28.08 |
| 2025-06-23 | 27.09 |
| 2025-06-20 | 26.64 |
| 2025-06-19 | 26.64 |
| 2025-06-18 | 27.47 |
| 2025-06-17 | 28.41 |
| 2025-06-16 | 29.30 |
| 2025-06-13 | 30.96 |
| 2025-06-12 | 30.68 |
| 2025-06-11 | 29.46 |
| 2025-06-10 | 29.35 |
| 2025-06-09 | 28.75 |
| 2025-06-06 | 27.25 |
| 2025-06-05 | 27.53 |
| 2025-06-04 | 27.86 |
| 2025-06-03 | 27.31 |
| 2025-06-02 | 27.58 |
| 2025-05-30 | 27.58 |
| 2025-05-29 | 28.47 |
| 2025-05-28 | 25.87 |
| 2025-05-27 | 26.20 |
| 2025-05-26 | 25.54 |
| 2025-05-23 | 26.37 |
| 2025-05-22 | 26.59 |
| 2025-05-21 | 27.31 |
| 2025-05-20 | 26.70 |
| 2025-05-19 | 26.26 |
| 2025-05-16 | 26.04 |
| 2025-05-15 | 26.37 |
| 2025-05-14 | 26.31 |
| 2025-05-13 | 25.59 |
| 2025-05-12 | 25.71 |
| 2025-05-09 | 25.54 |
| 2025-05-08 | 24.93 |
| 2025-05-07 | 23.99 |
| 2025-05-06 | 25.71 |
| 2025-05-02 | 26.64 |
| 2025-04-30 | 25.21 |
| 2025-04-29 | 25.54 |